Niraparib Maintenance Treatment Significantly Increased Outcomes for Ovarian Cancer Patients

Niraparib Maintenance Treatment Significantly Increased Outcomes for Ovarian Cancer Patients
Ovarian cancer patients with recurrent, platinum-sensitive disease may benefit greatly from niraparib maintenance treatment, according to data from a Phase 3 trial in which niraparib significantly prolonged patients’ progression-free survival compared to placebo. Findings of the study, “Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer,” were presented recently for the first time at the European Society for

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *